Adjuvant Ciprofloxacin for Persistent BK Polyomavirus Infection in Kidney Transplant Recipients

Table 3

Effect of ciprofloxacin on BKV infection.

		Patient 1	Patient 2	Patient 3	Patient 4	Patient 5	Patient 6	Patient 7	Patient 8	Patient 9
Viruria (copies/mL)	Before ciprofloxacin	2 * 10^6	4600 * 10^6	110 * 10^6	14 * 10^6	1300 * 10^6	>500 * 10^6	160 * 10^6	170 * 10^6	2 * 10^6
	Month 3	1015	30 * 10^6	7 * 10^6	9 * 10^6	3100 * 10^6	>500 * 10^6	357 * 10^6	330 * 10^6	44 * 10^6
	Clearance	Yes	>50%	>50%	No	No	No	No	No	No
Viremia (copies/mL)	Before ciprofloxacin	830	500	5400	13700	63000	93900	8500	10700	500
	Month 3	0	0	0	1600	167000	41100	4000	7300	3700
	Clearance	Yes	Yes	Yes	>50%	No	>50%	>50%	No	No
BVKAN		Yes	Yes	Yes	No	Yes	No	Yes	Yes	Yes

BKV: BK polyomavirus; BKVAN: BK polyomavirus associated nephropathy.